A bone scan in combination with some specific blood samples for the classification of bone disease in patients suffering from chronic kidney disease.

Phase 1

• Conditions: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), especially renal osteodystofi.; MedDRA version: 20.0 Level: LLT Classification code 10065404 Term: Combined positron emission tomogram and computerised tomogram System Organ Class: 10022891 - Investigations; MedDRA version: 20.0 Level: SOC Classification code 10022891 Term: Investigations System Organ Class: 10022891 - Investigations; MedDRA version: 20.0 Level: LLT Classification code 10066622 Term: Chronic hemodialysis System Organ Class: 100000004865; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]

• Registration Number: EUCTR2016-005160-34-DK
• Lead Sponsor: niversitetsklinikken for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro, Hospitalsenheden Vest

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-12-23
• Last Update Posted: 25 November 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Age 30-80 years
Chronic hemodialysis
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

Medical treatment with systemic corticosteroid
Inability to give informed consent
Pregnancy and lactation
Not radically treated cancer disease
Alcohol or drugs abuse
Within three months: bone fracture, AMI or TCI, parathyroidektomi or kidney transplantation

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified